Methylation at a transcription factor-binding site on the 5-HT1A receptor gene correlates with negative symptom treatment response in first episode schizophrenia

International Journal of Neuropsychopharmacology

Volumn 17, Issue 4, 2014, Pages 645-649

  Tang, Hao ^a,b   Dalton, Caroline F ^a   Srisawat, Umarat ^a   Zhang, Zhi Jun ^b   Reynolds, Gavin P ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Antipsychotic drugs; DNA methylation; HTR1A; negative symptoms; schizophrenia

Indexed keywords

BENZODIAZEPINE; CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; RISPERIDONE; SEROTONIN 1A RECEPTOR; TRANSCRIPTION FACTOR; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; EMOTIONAL DISORDER; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROMOTER REGION; REPRESSOR GENE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE; TREATMENT RESPONSE; BINDING SITE; CHINA; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANTIPSYCHOTIC AGENTS; BINDING SITES; CHINA; DNA METHYLATION; FEMALE; GENOTYPE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; RECEPTOR, SEROTONIN, 5-HT1A; SCHIZOPHRENIA; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896403505     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145713001442     Document Type: Article

References (20)

1. Aleman A, Kahn RS (2005) Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol 77:283-298.
2. Carrard A, Salzmann A, Malafosse A, Karege F (2011) Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. J Affect Disord 132:450-453.
3. Czesak M, Lemonde S, Peterson EA, Rogaeva A, Albert PR (2006) Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism. J Neurosci 26:1864-1871.
4. Diaz-Mataix L, Scorza MC, Bortolozzi A, Toth M, Celada P, Artigas F (2005) Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. J Neurosci 25:10831-10843.
5. Ghadirivasfi M, Nohesara S, Ahmadkhaniha HR, Eskandari MR, Mostafavi S, Thiagalingam S, Abdolmaleky HM (2011) Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 156B:536-545.
6. Ichikawa J, Ishii H, Bonaccorso S, Fowler WL, O'Laughlin IA, Meltzer HY (2001) 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 76:1521-1531.
7. Jacobsen KX, Vanderluit JL, Slack RS, Albert PR (2008) HES1 regulates 5-HT1A receptor gene transcription at a functional polymorphism: essential role in developmental expression. Mol Cell Neurosci 38:349-358.
8. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, Sequeira A, Kushwaha N, Morris SJ, Basak A, Ou XM, Albert PR (2003) Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23:8788-8799.
9. Lemonde S, Du L, Bakish D, Hrdina P, Albert PR (2004) Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response. Int J Neuropsychopharmacol 7:501-506.
10. Mossner R, Schuhmacher A, Kuhn KU, Cvetanovska G, Rujescu D, Zill P, Quednow BB, Rietschel M, Wolwer W, Gaebel W, Wagner M, Maier W (2009) Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia. Pharmacogenet Genomics 19:91-94.
11. Newman-Tancredi A, Kleven MS (2011) Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties. Psychopharmacology (Berl) 216:451-473.
12. Reynolds GP, Arranz B, Templeman LA, Fertuzinhos S, San L (2006) Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients. Am J Psychiatry 163:1826-1829.
13. Richardson-Jones JW, Craige CP, Nguyen TH, Kung HF, Gardier AM, Dranovsky A, David DJ, Guiard BP, Beck SG, Hen R, Leonardo ED (2011) Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J Neurosci 31:6008-6018.
14. Rosa A, Picchioni MM, Kalidindi S, Loat CS, Knight J, Toulopoulou T, Vonk R, van der Schot AC, Nolen W, Kahn RS, McGuffin P, Murray RM, Craig IW (2008) Differential methylation of the X-chromosome is a possible source of discordance for bipolar disorder female monozygotic twins. Am J Med Genet B Neuropsychiatr Genet 147B:459-462.
15. Silver H (2004) Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia. Expert Opin Pharmacother 5:2053-2058.
16. Sharma RP, Gavin DP, Grayson DR (2010) CpG methylation in neurons: message, memory, or mask? Neuropsychopharmacology 35:2009-2020.
17. Wallwork RS, Fortgang R, Hashimoto R, Weinberger DR, Dickinson D (2012) Searching for a consensus five-factor model of the positive and negative syndrome scale for schizophrenia. Schizophr Res 137:246-250.
18. Wang L, Fang C, Zhang A, Du J, Yu L, Ma J, Feng G, Xing Q, He L (2008) The-1019 C/G polymorphism of the 5-HT(1)A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients. J Psychopharmacol 22:904-909.
19. Yasuno F, Suhara T, Ichimiya T, Takano A, Ando T, Okubo Y (2004) Decreased 5-HT1A receptor binding in amygdala of schizophrenia. Biol Psychiatry 55:439-444.
20. Yevtushenko OO, Oros MM, Reynolds GP (2010) Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism. J Affect Disord 123:308-311.